Combination of Astragalus−Salvia and Ophiopogon−Dendrobium herb pairs alleviates Sjögren’s Syndrome via inhibiting the JAK1/STAT3 and PI3K/AKT pathways in NOD/Ltj mice

Abstract

Sjögren’s syndrome (SS) is an autoimmune disease characterized primarily by oral and periocular dryness. Astragalus-Salvia (AS) and Ophiopogon-Dendrobium (OD) represent two frequently utilized herb pairs in SS treatment. While the combination of AS-OD herb pairs demonstrates clinical efficacy in alleviating SS symptoms, its underlying mechanism remains unclear. This investigation sought to assess the therapeutic effects and elucidate the potential mechanisms of AS-OD in non-obese diabetic (NOD)/Ltj mice with SS. The study utilized NOD/Ltj mice as SS models, administering AS-OD treatment for 10 weeks at doses of 113.1, 226.2, and 339.3 mg·d⁻¹·20 g⁻¹. Results demonstrated that AS-OD improved SS symptoms, evidenced by enhanced salivary flow rate, decreased anti-SSA/Ro and anti-SSB/La antibody levels, increased swimming duration, and reduced lactate (LA) and blood urea nitrogen (BUN) levels in NOD/Ltj mice. AS-OD reduced lymphocyte infiltration, enhanced Aquaporin-5 (AQP5) expression in the submandibular gland, decreased inflammatory cytokine levels in the submandibular gland, and reduced the T helper type 17/regulatory T lymphocyte (Th17/Treg) cell ratio in the spleen. Transcriptomic and proteomic analyses indicated AS-OD’s involvement in regulating phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and Janus kinase 3/signal transducer and activator of transcription 3 (JAK1/STAT3) pathways, with inhibitory effects validated in both NOD/Ltj mice submandibular gland and A-253 cells. Furthermore, AS-OD enhanced cell viability and reduced A-253 cell apoptosis through the PI3K/AKT pathway. In A-253 cells, AS-OD reduced inflammatory cytokine levels, CXC chemokine ligand 9/10 (CXCL9/10), and T-cell chemotaxis by inhibiting the JAK1/STAT3 pathway. AS-OD mitigates SS by suppressing inflammation and immune responses through the PI3K/AKT and JAK1/STAT3 pathways.

Keywords

Sjgren’s syndrome / Astragalus-Salvia herb pair / Ophiopogon-Dendrobium herb pair / CXCL9 and CXCL10 / JAK1/STAT3 / PI3K/AKT

References

[1] Andre F, Bockle B C. Sjogren’s syndrome. J Dtsch Dermatol Ges. 2022; 20(7):980-1002. https://doi.org/10.1111/ddg.14823.

[2] Yura Y, Hamada M. Outline of salivary gland pathogenesis of Sjogren’s syndrome and current therapeutic approaches. Int J Mol Sci. 2023; 24(13):11179. https://doi.org/10.3390/ijms241311179.

[3] Ramos-Casals M, Brito-Zeron P, Bombardieri S, et al. EULAR recommendations for the management of Sjogren’s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020; 79(1):3-18. https://doi.org/10.1136/annrheumdis-2019-216114.

[4] Lysik D, Niemirowicz-Laskowska K, Bucki R, et al. Artificial saliva: challenges and future perspectives for the treatment of xerostomia. Int J Mol Sci. 2019; 20(13):3199. https://doi.org/10.3390/ijms20133199.

[5] Basones-Martinez A, Mattila R, Gomez-Font R, et al. Immunomodulatory drugs: oral and systemic adverse effects. Med Oral Patol Oral Cir Bucal. 2014; 19(1):e24-31. https://doi.org/10.4317/medoral.19087.

[6] Li D, Guo H, Niu L, et al. Clinical value-oriented research paradigm about inheritance and innovation development of TCM dominant diseases. Chin Herb Med. 2023; 15(4):476-84. https://doi.org/10.1016/j.chmed.2023.09.002.

[7] Liu J, Zhou H, Li Y, et al. Meta-analysis of the efficacy in treatment of primary sjogren’s syndrome: traditional Chinese medicine vs western medicine. J Tradit Chin Med. 2016; 36(5):596-605. https://doi.org/10.1016/S0254-6272(16)30078-4.

[8] Zhen W, Cao L, Du X. Progress in the compatibility mechanism of huangqi (Astragali Radix). J Liaoning Univ Tradit Chin Med. 2023; 25(10):205-9. https://doi.org/10.13194/j.issn.1673-842x.2023.10.039.

[9] Yang Y, Zhao Y, Zhang L. Analysis on the application characteristics of dendrobium in guide to clinical practice with medical records. Jilin J Chin Med. 2023; 43(06):720-3. https://doi.org/10.13463/j.cnki.jlzyy.2023.06.023.

[10] Qin Y, Lin C, Liu D, et al. Wangxinchang’s experience in treating Sjogren’s syndrome with method of invigorating qi, nourishing yin and removing blood stasis. Liaoning J Tradit Chin Med. 2018; 45(02):259-61. https://doi.org/10.13192/j.issn.1000-1719.2018.02.010.

[11] Ren Y, Liu D, Zhou D, et al. Effects of yiqi yangyin quyu prescription on the expression of AQP5 and M3R in submandibular glands of NOD mice with Sjogren syndrome. TC Drug Res Clin Pharmacol. 2023; 34(05):613-91. https://doi.org/10.19378/j.issn.1003-9783.2023.05.006.

[12] Karin N. CXCR3 ligands in cancer and autoimmunity, chemoattraction of effector T cells, and beyond. Front Immunol. 2020;11:976. https://doi.org/10.3389/fimmu.2020.00976.

[13] Kapsogeorgou EK, Stergiou IE, Chatzis L, et al. The role of the AKT signaling pathway in Sjogren’s syndrome. Mediterr J Rheumatol. 2023; 34(1):113-6. https://doi.org/10.31138/mjr.34.1.113.

[14] Benucci M, Bernardini P, Coccia C, et al. JAK inhibitors and autoimmune rheumatic diseases. Autoimmun Rev. 2023; 22(4):103276. https://doi.org/10.1016/j.autrev.2023.103276.

[15] Shiboski C H, Shiboski S C, Seror R, et al. 2016 American college of rheumatology/European league against rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017; 69(1):35-45. https://doi.org/10.1002/art.39859.

[16] Abughanam G, Maria O M, Tran S D. Studying Sjogren’s syndrome in mice: what is the best available model? J Oral Biol Craniofac Res. 2021; 11(2):245-55. https://doi.org/10.1016/j.jobcr.2020.12.001.

[17] Kamounah S, Taybo N, Chiang S, et al. Immunoassay detects salivary anti-SSA/Ro-52 autoantibodies in seronegative patients with primary Sjogren's syndrome. Immunohorizons. 2023; 7(7):554-61. https://doi.org/10.4049/immunohorizons.2300043.

[18] Chivasso C, D'Agostino C, PARISIS D, et al. Involvement of aquaporin 5 in Sjogren’s syndrome. Autoimmun Rev. 2023; 22(3):103268. https://doi.org/10.1016/j.autrev.2023.103268.

[19] Maeland E, Miyamoto ST, Hammenfors D, et al. Understanding fatigue in Sjogren’s syndrome: outcome measures, biomarkers and possible interventions. Front Immunol. 2021;12:703079. https://doi.org/10.3389/fimmu.2021.703079.

[20] Ogawa Y, Takeuchi T, Tsubota K. Autoimmune epithelitis and chronic inflammation in Sjogren's syndrome-related dry eye disease. Int J Mol Sci. 2021; 22(21):11820. https://doi.org/10.3390/ijms222111820.

[21] Wang J, Zhao X, Wan Y Y. Intricacies of TGF-beta signaling in Treg and Th17 cell biology. Cell Mol Immunol. 2023; 20(9):1002-22. https://doi.org/10.1038/s41423-023-01036-7.

[22] Knochelmann HM, Dwyer CJ, Bailey SR, et al. When worlds collide: Th17 and Treg cells in cancer and autoimmunity. Cell Mol Immunol. 2018; 15(5):458-69. https://doi.org/10.1038/s41423-018-0004-4.

[23] Fei Y, Zhang W, Lin D, et al. Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjogren’s syndrome. Clin Rheumatol. 2014; 33(4):523-9. https://doi.org/10.1007/s10067-013-2476-z.

[24] Matsui K, Sano H. T helper 17 cells in primary Sjogren’s syndrome. J Clin Med. 2017; 6(7):65. https://doi.org/10.3390/jcm6070065.

[25] Manganelli P, Fietta P.Apoptosis and Sjogren syndrome. Semin Arthritis Rheum. 2003; 33(1):49-65. https://doi.org/10.1053/sarh.2003.50019.

[26] Ren Y, Cui G, Gao Y. Research progress on inflammatory mechanism of primary Sjogren syndrome. Zhejiang Unvi J Med Sci. 2021; 50(6):783-94. https://doi.org/10.3724/zdxbyxb-2021-0072.

[27] Cai Y, Sun R, Wang R, et al. The activation of Akt/mTOR pathway by bleomycin in epithelial-to-mesenchymal transition of human submandibular gland cells: a treatment mechanism of bleomycin for mucoceles of the salivary glands. Biomed Pharmacother. 2017; 90:109-15. https://doi.org/10.1016/j.biopha.2017.02.098.

[28] Jiang CH, Xi Z, Jia W, et al. Andrographolide sulfonate alleviates rheumatoid arthritis by inhibiting glycolysis-mediated activation of PI3K/AKT to restrain Th17 differentiation. Chin J Nat Med. 2024; 22(4):1-15. https://doi.org/10.1016/S1875-5364(24)60627-8.

[29] Banerjee S, Biehl A, Gadina M, et al. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs. 2017; 77(5):521-46. https://doi.org/10.1007/s40265-017-0701-9.

[30] Li S, Fan G, Li X, et al. Modulation of type I interferon signaling by natural products in the treatment of immune-related diseases. Chin J Nat Med. 2023; 21(1):3-18. https://doi.org/10.1016/S1875-5364(23)60381-4.

[31] Zhang J, Zhang X, Shi X, et al. CXCL9, 10, 11/CXCR3 axis contributes to the progress of primary Sjogren’s syndrome by activating GRK2 to promote T lymphocyte migration. Inflammation. 2023; 46(3):1047-60. https://doi.org/10.1007/s10753-023-01791-9.

[32] Han XY, Xu N, Yuan JF, et al. Total flavonoids of Astragalus inhibit activated CD4⁺T cells and regulate differentiation of Th17/Th1/Treg cells in experimental autoimmune encephalomyelitis mice by JAK/STAT and NFκB signaling pathways. Am J Chin Med. 2023; 51(5):1233-48. https://doi.org/10.1142/S0192415X23500568.

[33] Wang W, Li J, Ding Z, et al. Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway. J Cell Mol Med. 2019; 23(9):6454-65. https://doi.org/10.1111/jcmm.14539.

[34] Zhang Y, Li C, Li S, et al.Dihydrotanshinone I alleviates crystalline silica-induced pulmonary inflammation by regulation of the Th immune response and inhibition of STAT1/STAT3. Mediators Inflamm. 2019;2019:3427053. https://doi.org/10.1155/2019/3427053.

[35] Lin Q, Zhang Q. Effects of Astragalus membranaceus and Salvia miltiorrhiza on the expression of aquaporin-5 in submandibular glands of rat with Sjogren’s syndrome. Stomatology. 2010; 30(08):473-6. https://doi.org/10.13591/j.cnki.kqyx.2010.08.002.

[36] Li Z, Sun Q, Liu Q, et al. Compound 511 ameliorates MRSA-induced lung injury by attenuating morphine-induced immunosuppression in mice via PI3K/AKT/mTOR pathway. Phytomedicine. 2023;108: 154475. https://doi.org/10.1016/j.phymed.2022.154475.

[37] Lin X, Shaw PC, Sze SC, et al. Dendrobium officinale polysaccharides ameliorate the abnormality of aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis in the experimental Sjogren’s syndrome mice. Int Immunopharmacol. 2011; 11(12):2025-32. https://doi.org/10.1016/j.intimp.2011.08.014.

[38] Tsai SW, Wang JH, Chang YK, et al. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation. Open Life Sci. 2023; 18(1):20220703. https://doi.org/10.1515/biol-2022-0703.